DDW 2020: Study Reveals Economic/Racial Disparities in the Management of Gastric and Pancreatic Cancers
Patients who are white, with private insurance, and higher incomes were more likely to receive neoadjuvant chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.